PRESS RELEASES & STATEMENTS

      • 8 April, 2019

    Guidelines and Regulations Necessary as Stem Cell Field Advances

    With the rapid growth of the stem cell field and advances in regenerative medicine, it is critically important that researchers earn and retain the public trust. To that end we must operate under agreed-upon guidelines that ensure ethical activities, transparency, and sound science.
    Full story
      • 29 March, 2019

    ISSCR Comments on New Biomedical Technology Regulations in China

    In response to draft regulations in China on gene editing and other potentially risky biomedical technologies, the ISSCR has submitted comments to the the country's National Health Commission Medical and Medical Administration Bureau.
    Full story
      • 13 March, 2019

    ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research

    The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos.
    Full story
      • 11 March, 2019

    ISSCR 2019 Election Results

    ISSCR has elected its next leadership slate, with leaders beginning their terms after the 2019 annual meeting. On behalf of all members, we extend congratulations to newly-elected officers Melissa Little, vice president; and Kenneth Zaret, treasurer, and re-appointed board members Marianne Bronner, Valentina Greco, and Arnold Kriegstein.
    Full story
      • 8 March, 2019

    Sharing Excellent Science and Growing Personal Networks

    Each year our annual ISSCR meeting showcases for the world the potential of stem cell science and advances already underway that are changing the face of human healthcare. We highlight the latest innovative research and scientific developments that are propelling the field forward in a variety of ways. ISSCR 2019 in Los Angeles is a terrific opportunity to inspire us with research at the leading-edge of scientific discovery
    Full story
      • 25 February, 2019

    Progress in Stem Cell Science & Regenerative Medicine On Tap in Los Angeles, 26-29 June

    Top scientists and researchers from academia, medicine, and industry will gather to share groundbreaking stem cell science and its translation to clinical application at the annual meeting of the International Society for Stem Cell Research (ISSCR), 26-29 June in Los Angeles, Calif.
    Full story
      • 22 February, 2019

    Advocating for Science and Research

    Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'
    Full story
      • 8 February, 2019

    ISSCR Announces 2019 Award Recipients

    The ISSCR announces the recipients of its 2019 Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award. Awardees will be recognized at the ISSCR annual meeting, 26-29 June, in Los Angeles, Calif., U.S.
    Full story
      • 8 February, 2019

    New Voices, Breakthrough Science at ISSCR 2019

    If you’re an enterprising stem cell scientist with exciting work to publish this year, the ISSCR annual meeting in Los Angeles, 26-29 June, is the place to take the stage and showcase your science to colleagues and the field. We’ve developed a new program structure this year that dedicates 15 plenary speaking spots to abstract-selected speakers, to showcase the talents of the next generation of scientists.
    Full story
      • 21 January, 2019

    ISSCR Introduces Chief Operating Officer Keith Alm

    Keith Alm joined the ISSCR as chief operating officer in January 2019, after serving as a brand strategist and consultant for the society for nearly a decade. He’s worked with many of the organization's leaders on strategic positioning, communications, and partnerships.
    Full story
      • 4 January, 2019

    Standing Up for Scientific Research

    The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.
    Full story
      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 5 December, 2018

    2018 ISSCR Year in Review

    Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 November, 2018

    New Perspectives in Stem Cell Reports

    In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.
    Full story
      • 12 November, 2018

    Convergence of Stem Cell Science and Medicine

    Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story
      • 5 October, 2018

    Developing Trainees, Expanding Horizons

    I take seriously my responsibility to support and nurture future generations of stem cell scientists. Indeed, it is critical for all of us in this evolving field to help trainees and others coming up in the field, to ensure they have opportunities to learn, grow, make connections, and share their science.
    Full story
      • 2 October, 2018

    ISSCR Comments on Horizon Europe

    The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.
    Full story
      • 2 October, 2018

    ISSCR Voice is Heard on Capitol Hill

    In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.
    Full story
      • 27 September, 2018

    ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research

    The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.
    Full story
      • 10 September, 2018

    ISSCR Journal Focuses on Women in Stem Cell Science; Reflections by CEO Nancy Witty

    The ISSCR has always had strong female leaders, and many of them are featured in the September and October editions of Stem Cell Reports.
    Full story
      • 6 September, 2018

    Energizing for Renewed Focus

    Many of us find time in the summer to reflect on work and recharge our batteries. Vacations, visits with friends, and time with family all help get away from everyday concerns in the lab and gain some perspective to inform the scientific path for the year ahead.
    Full story
      • 23 August, 2018

    Nominate for ISSCR Awards and Leadership Positions

    The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story
      • 17 July, 2018

    2018 ISSCR Annual Meeting Wrap-up

    The ISSCR 2018 Annual Meeting went “down under” to Melbourne, Australia where 3,000 stem cell scientists, clinicians, and professionals from 52 countries gathered to share their latest research, network with colleagues, and explore the latest technologies driving the field forward.
    Full story
      • 22 June, 2018

    Douglas A. Melton Becomes President of the ISSCR

    The ISSCR is pleased to announce Douglas A. Melton, PhD, Harvard University, as the incoming president of the ISSCR and its board of directors. Melton assumed the post on 23 June, 2018, immediately following the 16th ISSCR Annual Meeting in Melbourne, Australia.
    Full story
      • 20 June, 2018

    ISSCR Announces New Editor-in-chief for Stem Cell Reports Journal

    The ISSCR has appointed Martin F. Pera, professor at the Jackson Laboratory, U.S., as the next editor-in-chief of Stem Cell Reports, the organization’s open-access journal. Pera will succeed Christine Mummery, who led the journal since its launch in 2013. Pera will assume the post in January, 2019.
    Full story
      • 14 June, 2018

    ISSCR Opposes Proposal to Restrict Fetal Tissue Research

    The ISSCR opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released a statement on the issue.
    Full story
      • 23 May, 2018

    ISSCR Announces Hamburg, Germany as Site of 2021 Annual Meeting

    The ISSCR will hold its 2021 annual meeting in Hamburg, Germany, the first time the organization will be meeting in that city. The meeting is expected to draw 4,000 stem cell researchers and professionals from around the globe to the Congress Center Hamburg, scheduled to open in 2019. The meeting will be held 23-26 June, 2021.
    Full story
      • 4 June, 2018

    ISSCR Responds to President Trump Signing 'Right to Try' Law

    The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
    Full story
      • 10 May, 2018

    ISSCR Applauds Federal Injunctions Against Stem Cell Clinics

    The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation.
    Full story
      • 7 May, 2018

    Active Support for Stem Cell Research Around the World

    Scientific progress requires that legislators and regulators around the world recognize and appreciate the value of research and actively support pro-science policies. The ISSCR, through its policy program, champions the advancement of stem cell research and its translation to medicine.
    Full story
      • 30 April, 2018

    ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine

    Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.
    Full story
      • 26 April, 2018

    ISSCR Applauds Australia’s Move to Regulate Autologous Human Cell and Tissue Products

    The ISSCR appreciates the new framework proposed by Australia’s Therapeutic Goods Administration (TGA) for the regulation of human cell and tissue products that use a person’s own cells (‘autologous use’).
    Full story
      • 19 April, 2018

    ISSCR Advocates for Stem Cells and Basic Research in Europe

    ISSCR members and staff met 12 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation.
    Full story
      • 9 April, 2018

    Collaborations for Improving Human Health

    Like many stem cell researchers, my work is increasingly focused on developing ways to translate basic scientific discovery into treatments that help people suffering from disease or injury. The potential for stem cell therapies initially fascinated me as a developmental biologist, and over time I’ve learned the very real impact that our science can have on human health.
    Full story
      • 3 April, 2018

    ISSCR Advocates for Science Investment in Letter to European Commission

    In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe.
    Full story
      • 21 March, 2018

    Media Registration Open for ISSCR 2018 20-23 June, Melbourne, AUS

    Credentialed reporters can register and attend the 2018 annual meeting in Melbourne, Australia. They will have access to the many stem cell researchers and clinicians from around the world who will be discussing recent findings and progress that is driving development of stem cell treatments and cures for disease.
    Full story
      • 14 March, 2018

    ISSCR Announces Recipients of 2018 Awards

    Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.
    Full story
      • 12 March, 2018

    'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed

    The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.
    Full story
      • 12 March, 2018

    ISSCR 2018 Election Results

    The ISSCR is pleased to announce the results of its 2018 leadership election. On behalf of all members, we extend congratulations to newly-elected officers and board members.
    Full story
      • 12 March, 2018

    Scientific Excellence at ISSCR 2018

    Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.
    Full story
      • 15 February, 2018

    ISSCR Releases Guidebook to Evaluate Cell Therapy Trials

    The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.
    Full story
      • 9 February, 2018

    Showcasing Inspiring Science and Natural Beauty

    There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
    Full story
      • 7 February, 2018

    Stem Cell Reports Seeking Editor-in-Chief

    The ISSCR’s official journal, Stem Cell Reports, is seeking applications for a new Editor-in-Chief to succeed Christine Mummery, who has served in that role since the journal's inception in 2012.
    Full story
Anne-AM17

Anne Nicholas

Director of Communications +1 847-929-4818 (o) +1 202-746-0866 (m)

Email Anne Nicholas